583 related articles for article (PubMed ID: 25482636)
61. EphB4 forward signalling regulates lymphatic valve development.
Zhang G; Brady J; Liang WC; Wu Y; Henkemeyer M; Yan M
Nat Commun; 2015 Apr; 6():6625. PubMed ID: 25865237
[TBL] [Abstract][Full Text] [Related]
62. Ephrin type-B receptor 4 activation reduces neointimal hyperplasia in human saphenous vein in vitro.
Wong DJ; Lu DY; Protack CD; Kuwahara G; Bai H; Sadaghianloo N; Tellides G; Dardik A
J Vasc Surg; 2016 Mar; 63(3):795-804. PubMed ID: 25446283
[TBL] [Abstract][Full Text] [Related]
63. Therapeutic interference with EphrinB2 signalling inhibits oxygen-induced angioproliferative retinopathy.
Ehlken C; Martin G; Lange C; Gogaki EG; Fiedler U; Schaffner F; Hansen LL; Augustin HG; Agostini HT
Acta Ophthalmol; 2011 Feb; 89(1):82-90. PubMed ID: 19764912
[TBL] [Abstract][Full Text] [Related]
64. PSGL-1-mediated activation of EphB4 increases the proangiogenic potential of endothelial progenitor cells.
Foubert P; Silvestre JS; Souttou B; Barateau V; Martin C; Ebrahimian TG; Leré-Déan C; Contreres JO; Sulpice E; Levy BI; Plouët J; Tobelem G; Le Ricousse-Roussanne S
J Clin Invest; 2007 Jun; 117(6):1527-37. PubMed ID: 17510705
[TBL] [Abstract][Full Text] [Related]
65. Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment.
Das A; Shergill U; Thakur L; Sinha S; Urrutia R; Mukhopadhyay D; Shah VH
Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G908-15. PubMed ID: 20338920
[TBL] [Abstract][Full Text] [Related]
66. Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway.
Miao H; Wei BR; Peehl DM; Li Q; Alexandrou T; Schelling JR; Rhim JS; Sedor JR; Burnett E; Wang B
Nat Cell Biol; 2001 May; 3(5):527-30. PubMed ID: 11331884
[TBL] [Abstract][Full Text] [Related]
67. Spatiomechanical Modulation of EphB4-Ephrin-B2 Signaling in Neural Stem Cell Differentiation.
Dong M; Spelke DP; Lee YK; Chung JK; Yu CH; Schaffer DV; Groves JT
Biophys J; 2018 Sep; 115(5):865-873. PubMed ID: 30075851
[TBL] [Abstract][Full Text] [Related]
68. The role of the vascular endothelial growth factor-Delta-like 4 ligand/Notch4-ephrin B2 cascade in tumor vessel remodeling and endothelial cell functions.
Hainaud P; Contrerès JO; Villemain A; Liu LX; Plouët J; Tobelem G; Dupuy E
Cancer Res; 2006 Sep; 66(17):8501-10. PubMed ID: 16951162
[TBL] [Abstract][Full Text] [Related]
69. Mesenchymal stem cells overexpressing ephrin-b2 rapidly adopt an early endothelial phenotype with simultaneous reduction of osteogenic potential.
Duffy GP; D'Arcy S; Ahsan T; Nerem RM; O'Brien T; Barry F
Tissue Eng Part A; 2010 Sep; 16(9):2755-68. PubMed ID: 20491587
[TBL] [Abstract][Full Text] [Related]
70. Inhibition of Ephrin-B2 in brain pericytes decreases cerebral pathological neovascularization in diabetic rats.
Coucha M; Barrett AC; Elgebaly M; Ergul A; Abdelsaid M
PLoS One; 2019; 14(1):e0210523. PubMed ID: 30620753
[TBL] [Abstract][Full Text] [Related]
71. Study of angiogenic signaling pathways in hemangioblastoma.
Pierscianek D; Wolf S; Keyvani K; El Hindy N; Stein KP; Sandalcioglu IE; Sure U; Mueller O; Zhu Y
Neuropathology; 2017 Feb; 37(1):3-11. PubMed ID: 27388534
[TBL] [Abstract][Full Text] [Related]
72. Multitargeting strategy using lenvatinib and golvatinib: maximizing anti-angiogenesis activity in a preclinical cancer model.
Nakazawa Y; Kawano S; Matsui J; Funahashi Y; Tohyama O; Muto H; Nakagawa T; Matsushima T
Cancer Sci; 2015 Feb; 106(2):201-7. PubMed ID: 25458359
[TBL] [Abstract][Full Text] [Related]
73. EphB4 signaling is capable of mediating ephrinB2-induced inhibition of cell migration.
Sturz A; Bader B; Thierauch KH; Glienke J
Biochem Biophys Res Commun; 2004 Jan; 313(1):80-8. PubMed ID: 14672701
[TBL] [Abstract][Full Text] [Related]
74. Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms.
Erber R; Thurnher A; Katsen AD; Groth G; Kerger H; Hammes HP; Menger MD; Ullrich A; Vajkoczy P
FASEB J; 2004 Feb; 18(2):338-40. PubMed ID: 14657001
[TBL] [Abstract][Full Text] [Related]
75. Eph-B2/ephrin-B2 interaction plays a major role in the adhesion and proliferation of Waldenstrom's macroglobulinemia.
Azab F; Azab AK; Maiso P; Calimeri T; Flores L; Liu Y; Quang P; Roccaro AM; Sacco A; Ngo HT; Zhang Y; Morgan BL; Carrasco RD; Ghobrial IM
Clin Cancer Res; 2012 Jan; 18(1):91-104. PubMed ID: 22010211
[TBL] [Abstract][Full Text] [Related]
76. Ephrin-independent regulation of cell substrate adhesion by the EphB4 receptor.
Noren NK; Yang NY; Silldorff M; Mutyala R; Pasquale EB
Biochem J; 2009 Aug; 422(3):433-42. PubMed ID: 19552627
[TBL] [Abstract][Full Text] [Related]
77. Regulation of vascular endothelial growth factor receptor function in angiogenesis by numb and numb-like.
van Lessen M; Nakayama M; Kato K; Kim JM; Kaibuchi K; Adams RH
Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1815-25. PubMed ID: 26069237
[TBL] [Abstract][Full Text] [Related]
78. Contribution of Endothelial-to-Mesenchymal Transition to the Pathogenesis of Human Cerebral and Orbital Cavernous Malformations.
Takada S; Hojo M; Tanigaki K; Miyamoto S
Neurosurgery; 2017 Jul; 81(1):176-183. PubMed ID: 28368503
[TBL] [Abstract][Full Text] [Related]
79. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium.
Paavonen K; Mandelin J; Partanen T; Jussila L; Li TF; Ristimaki A; Alitalo K; Konttinen YT
J Rheumatol; 2002 Jan; 29(1):39-45. PubMed ID: 11824969
[TBL] [Abstract][Full Text] [Related]
80. Ephrin-B2/Fc promotes proliferation and migration, and suppresses apoptosis in human umbilical vein endothelial cells.
Zheng LC; Wang XQ; Lu K; Deng XL; Zhang CW; Luo H; Xu XD; Chen XM; Yan L; Wang YQ; Shi SL
Oncotarget; 2017 Jun; 8(25):41348-41363. PubMed ID: 28489586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]